Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 13;44(2 Suppl 1):S67–S81. doi: 10.14639/0392-100X-suppl.1-44-2024-N2966

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy

This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

PMC Copyright notice

Figure 1. — A) endoscopic appearance of the lesion during first examination; B) MRI showing a polypoid mass (10 x 7 mm in axial dimension) arising from the distal nasolacrimal duct, mildly hypo-intense on T1 and T2-weighted images, and avidly enhancing on post-contrast images with hypo-intense borders; C) follow-up MRI at 6 months after surgery showing no evidence of recurrence; D) endoscopic follow-up at 6 months after surgery showing no recurrence with residual nasolacrimal duct patency (white arrow: infraorbital nerve; white ring: opening of residual nasolacrimal duct, blue line: middle turbinate residue).